Recent approval to the cancer drug 'Velcade' by FDA has provided
new hope to patients suffering from Mantle Cell Lymphoma, an aggressive
form of Non-Hodgkin's Lymphoma. Mantle Cell Lymphoma is a disease,
which cannot be cured with standard chemotherapy and Velcade is the
first drug to receive FDA's approval for the treatment of this
disease. Watch this video to know more about this drug.